Target Groups
- Women with a history of spontaneous preterm birth
- Pregnant women with an incidentally discovered short cervix
- Medically identified high-risk pregnancies
A specialized medical program designed to reduce preterm birth risks using progesterone therapy, ensuring a safer pregnancy duration and protecting the fetus from complications of early delivery.
Scientific name: Progesterone Supplementation for Preterm Birth Prevention
This program involves administering progesterone via injection or vaginal route for women with a history of preterm birth or short cervix, under strict medical supervision to maintain pregnancy stability.